Celesio AG Shareholder Elliott Remains Opposed To McKesson Corporation Bid

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Hedge fund Elliott International remains opposed to U.S. wholesale drugs group McKesson's (MCK.N) $8.3 billion offer for European counterpart Celesio (CLSGn.DE), it said on Monday, warning it was "irrevocably bound" not to accept the bid in its current form. McKesson, the largest U.S. drugs wholesale group, agreed to buy Celesio in October for 23 euros per share in cash, seeking to expand abroad and boost its purchasing power with pharma majors.

Help employers find you! Check out all the jobs and post your resume.

Back to news